IMPACT IMPROVING PATIENT ACCESS TO CLINICAL TRIALS
USPTO (United States) · Serial 86863341
- Status
- registered
- Status updated
- 6 June 2017
- Filing date
- 31 December 2015
- Registration date
- 6 June 2017
- Nice classification
- 36, 41
- Owner
- Lazarex Cancer Foundation
- Owner country
- US
- Raw status code
- 700
As filed by US
Authoritative source
The official US trademark record is at USPTO TSDR (serial 86863341) ↗. Where our data differs from the USPTO record, theirs is correct.
See methodology for refresh cadence + status normalisation. See sources for licensing.